New Jersey Supreme Court Reaffirms Accutane as the Controlling Standard for the Admissibility of Expert Testimony

Short summary

The New Jersey Supreme Court reaffirmed the Accutane gatekeeping framework as the controlling standard for expert testimony admissibility under N.J.R.E. 702 and 703. In Beavan v. Allergan, the Court emphasized that trial judges must scrutinize both expert methodology and underlying data, and may apply Daubert factors where relevant. The decision also encouraged Rule 104 hearings for resolving complex causation disputes.

• •NJ Supreme Court reaffirms Accutane standard for expert testimony admissibility
• •Beavan v. Allergan reinforces rigorous gatekeeping on methodology and data
• •Rule 104 hearings strongly encouraged for contested expert evidence

Generated with AI, which can make mistakes.